Search
for

    Glossary Everolimus

    medication that inhibits mTOR pathway, used in cancer treatment

    Everolimus is a medication that inhibits the mTOR (mammalian target of rapamycin) pathway, which is crucial for cell growth and proliferation. It is commonly used in cancer treatment to slow tumor growth and in organ transplantation to prevent rejection. Additionally, it has applications in treating certain rare diseases and conditions like tuberous sclerosis complex.

    Sort by

    Research 30 of 90

    1. Gingival Hyperplasia Secondary to Everolimus Therapy Actas Dermo-Sifiliográficas · 2010
    2. Cutaneous Toxicities From Transplantation-Related Medications American Journal of Transplantation · 2017 · 14 citations
    3. ТУБЕРОЗНЫЙ СКЛЕРОЗ (БУРНЕВИЛЛЯ-ПРИНГЛА). ОБЗОР ЛИТЕРАТУРЫ 2026
    4. Virilizing insulinoma Endokrynologia Polska · 2025
    5. TRAPPED IN THE HYPOGLYCEMIA LOOP Journal of the ASEAN Federation of Endocrine Societies · 2025
    6. Contact Allergic Dermatitis to Quinine in an Anti-hair Loss Lotion Actas Dermo-Sifiliográficas · 2010
    7. Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study Pediatric Blood & Cancer · 2019 · 16 citations
    8. Index 2013
    9. Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition Cell Cycle · 2006 · 295 citations
    10. Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review) Oncology Reports · 2012 · 46 citations
    11. Alopecia in patients treated with molecularly targeted anticancer therapies Annals of Oncology · 2015 · 44 citations
    12. TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia Cell Death and Disease · 2016 · 38 citations
    13. Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis Nature Communications · 2011 · 36 citations
    14. Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis Expert Review of Anticancer Therapy · 2017 · 28 citations
    15. Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology Clinical & Translational Oncology · 2018 · 26 citations
    16. Fibrous Papule of the Face, Similar to Tuberous Sclerosis Complex-Associated Angiofibroma, Shows Activation of the Mammalian Target of Rapamycin Pathway: Evidence for a Novel Therapeutic Strategy? PLoS ONE · 2014 · 12 citations
    17. Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs Cancers · 2019 · 11 citations
    18. Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids Annals of Dermatology · 2008 · 8 citations
    19. Malignant epithelial tumors: Part II. Therapy and prevention Journal der Deutschen Dermatologischen Gesellschaft · 2013 · 5 citations
    20. Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database Frontiers in Pharmacology · 2025 · 2 citations
    21. Dermatologic Care of the Transplant Patient Journal of the Dermatology Nurses’ Association · 2010 · 2 citations
    22. Adverse Hair Reactions to New Targeted Therapies for Cancer Actas Dermo-Sifiliográficas · 2019 · 1 citations
    23. Industry update: the latest developments in the field of therapeutic delivery, July 2018 Therapeutic Delivery · 2018 · 1 citations
    24. Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation Frontiers in Pharmacology · 2026
    25. ИХТИОЗ АРЛЕКИНО: КЛИНИЧЕСКИЙ СЛУЧАЙ 2026
    26. ИСПОЛЬЗОВАНИЕ ПОЛИНУКЛЕОТИДОВ В АНТИВОЗРАСТНОЙ ИНЪЕКЦИОННОЙ КОСМЕТОЛОГИИ С ПОЗИЦИИ ДОКАЗАТЕЛЬНОЙ МЕДИЦИНЫ 2026
    27. RTHP-40. EFFECT OF RIND-BASED DOSIMETRIC TECHNIQUES FOR SCALP DOSE REDUCTION IN BRAIN IRRADIATION Neuro-oncology · 2019
    28. Benign Cutaneous Eruptions After Transplantation Springer eBooks · 2017
    29. Oral Presentations Pediatric Dermatology · 2017
    30. Finasteride Reactions Weekly · 2011